
ASX 200 Morning Market Outlook: CSL Plunge Drags ASX lower
CSL’s 15% slump pulls the ASX 200 lower as healthcare and materials weigh, while sector correlations weaken and momentum turns cautious.
Share this:

The ASX 200 fell on Tuesday as biotech heavyweight CSL suffered a 15% plunge following a revenue downgrade, marking its worst day since August. The selloff dragged the healthcare and materials sectors lower, offsetting modest gains in financials. With key correlations to Wall Street indices weakening and momentum indicators turning cautious, traders are questioning whether the local market is preparing for a broader retracement.
View related analysis:
View related analysis:
CSL Slump and Weak Correlations Pressure ASX 200
ASX 200 Market Snapshot
- The ASX 200 recorded its worst session in four days, though losses were cushioned by strength in the Financials sector (XFJ).
- Five of eleven ASX sectors advanced, led by Consumer Discretionary and Financials, while six declined — with Health Care (XHJ) and Materials (XMJ) leading losses.
- Health Care and Information Technology have been the weakest-performing ASX sectors over the past 60 trading days.
- A two-bar bearish reversal (dark cloud cover) has formed on the daily chart, again highlighting weakness within the upper wicks of the past two weekly candles.
- Wednesday remains the most volatile trading day, with an average daily range of 79.9 points over the past three months and 75.1 points over the past year.

Chart analysis by Matt Simpson - source: ASX, LSEG
CSL Plunges to Six-Year Low as US Immunisation Slump Hits Revenue
Biotech firm CSL fell 15% on Tuesday, suffering its worst day since August following a revenue guidance downgrade. The company cited an unprecedented decline in US immunisation rates and said it has yet to see a bottom. The heavy losses weighed on the broader ASX 200 index, with CSL being the fourth-largest company by market capitalisation.
I noted in Tuesday’s report that the healthcare sector appeared to be rolling over and that CSL was a bellwether stock to monitor. CSL now sits at a six-year low, and further losses could be ahead, with bears likely eyeing a move toward the November 2018 low of 158.43. Also note the 200-month EMA sits at 171.60 for a potential support level along the way.

Chart analysis by Matt Simpson – Source: TradingView.
ASX 200 Correlations
The ASX 200 appears to be dancing to its own beat across the 10-, 20-, and 60-day correlations. Its relationship with Wall Street indices has effectively broken down over the past 10 days, with the Nasdaq 100 and S&P 500 pushing to record highs while ASX momentum turns lower. Even the usually solid correlations between the ASX 200 and its two largest sectors — Financials and Materials — are waning. This suggests smaller-cap stocks are driving short-term moves. With Materials beginning to turn, the question is whether the ASX is finally due for a deeper retracement.

Chart analysis by Matt Simpson - data source: ASX, LSEG
ASX 200 Technical Analysis
The two-bar bearish reversal (dark cloud cover) was accompanied by rising volumes on Tuesday, suggesting bears are attempting to regain control of the ASX 200 futures market. The near-term bias favours a move toward 9,000, with a break below that level exposing the 8,950 lows.
However, the 1-hour chart shows support around Thursday’s VPOC (9,033) and the weekly pivot point (9,041). If CPI data proves soft enough to increase expectations of an RBA rate cut today, the ASX could see a short-term rebound on policy optimism.
At that stage, I would reassess the potential for a swing high, with 9,000 remaining the initial downside target.

Chart analysis by Matt Simpson - Source: TradingView, ASX SPI 200 Index Futures
-- Written by Matt Simpson
Follow Matt on Twitter @cLeverEdge
How to trade with City Index
You can trade with City Index by following these four easy steps:
- Open an account, or log in if you’re already a customer
• Open an account in the UK
• Open an account in Australia
• Open an account in Singapore
- Search for the market you want to trade in our award-winning platform
- Choose your position and size, and your stop and limit levels
- Place the trade
Related tags:
Open an account today
Experience award-winning platforms with fast and secure execution.
Economic calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.

ASX 200 On Track for Worst Week in Four Years, Raising Bear Market Fears
The ASX 200 faces its worst week in four years as falling commodities, China's economic weakness and broad-based selling threaten a deeper correction.

S&P 500 Analysis: SPX Is Going Through One of Its Most Difficult Periods of 2026
Confidence around the U.S. equity market continues to face significant pressure. Over the last three trading sessions alone, the S&P 500 has fallen nearly 3.3%, highlighting a bearish bias that has become increasingly evident across the broader market.

Nasdaq 100 forecast: Markets turn jittery as Anthropic debuts at 34% above IPO
Nasdaq futures were up some 2% earlier, but shortly after the Anthropic debut, the index slumped to session lows, down more than 1.5%, before bouncing back from the lows at the time of writing. Much of the selling for the Nasdaq was driven by AMD which slumped nearly 10% after a Hunterbrook Media report raised fresh questions about the company’s exposure to US export controls on China.
From time to time, StoneX Financial Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.
As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.









